תבנית:תרופה/אופלוקסצינה - Ofloxacina
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | J01MA Fluoroquinolones |
|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | ת××-×ר××× - I.V |
| צ×רת ××× ×× | ת×××¡× ×××× ×¤××××, SOLUTION FOR INFUSION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | Infections of kidney, urinarty tract, genital organs, respiratory tract, chronic and recurrent ear, nose and throat, skin and soft tissues, bones and joints, bacterial enteritis, abdominal cavity, including pelvis minor and septicemia caused by ofloxacin sensitive microorganisms. Prevention of infections in patients with a signifcant reduction of resistance to infections.
|
| ת×× ×ת:× ×ª×× × ×¡×/תר×פ×/××פ××קסצ×× × - Ofloxacina | |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  |
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ××פ××קסצ×× × ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | - |
|---|---|
| ××××¢ ×רשת | - |
| ×©× ××¦×¨× | B.BRAUN MEDICAL S.A., SPAIN |
| ×©× ××¢× ×ר×ש×× | BIOAVENIR LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 01/2004. ר×ש××× ×ת×ר××: 01/2015 |
| ת×ר×× ×¢×××× ××ר×× | 14/05/19 |
××£ ×× × ×צר ×¢× ××× ××× ×××××ר ת×× ×ת ×¢× ×¤×¨×× ×תר×פ×.
- ××£ ×תר×פ×: ××פ××קסצ×× × - Ofloxacina
- ××ר××¡× ××× ×ת ×©× ×¤×¨×× ×תר×פ×: × ××ª× ×ער×× ×ת ××£ ×תר××¤× ××¢××. ×××××× ×××××¤× ×ת:
{{תר×פ×/××פ××קסצ×× × - Ofloxacina}}
×:
{{תר×פ×/××פ××קסצ×× × - Ofloxacina
| ×©× ×פר××ר=×¢×¨× ××ש (××רס ×ת ××¢×¨× ×©×××× ××××ר)
}}
השינוי האחרון נעשה בֹ־26 באפריל 2022 ב־13:35